Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Essner

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Cancer Journal (Sudbury, Mass.)|June 29, 2006
Can surgical therapy alone achieve long-term cure of melanoma metastatic to regional nodes?Shawn E Young, Steve R Martinez, Mark B Faries, et al.
Journal of Cutaneous Pathology|January 12, 2019
Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimenAndrew B Siref, Carissa A T Huynh, Bonnie L Balzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Humoral immune response to a therapeutic polyvalent cancer vaccine after complete resection of thick primary melanoma and sentinel lymphadenectomyMathew H Chung, Rishab K Gupta, Eddy Hsueh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2005
Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanomaJohn C Kang, Leslie A Wanek, Richard Essner, et al.
JAMA Surgery|July 23, 2025
Metastatic Melanoma Outcomes and the Evolving Role of Surgery in the Immunotherapy EraHilary R Keller, Douglas A Hanes, Jillian K McCabe, et al.
Dermatology and Therapy|June 23, 2026
Comparing the i31-SLNB and the MIA Nomogram for Sentinel Lymph Node Biopsy Positivity Prediction in Cutaneous Melanoma: A Prospective Cohort AnalysisRohit Sharma, Rajan P Kulkarni, Richard Essner, et al.
Clinical Nuclear Medicine|December 10, 2003
The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision makingSeza A Gulec, Mark B Faries, Chris C Lee, et al.
Cancer Medicine|November 29, 2024
Individualized Prediction for Risk of Recurrence in Stage I/II Melanoma Patients With Negative Sentinel Lymph NodeShu-Ching Chang, Kristel Lourdault, Gary L Grunkemeier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanomaHitoe Torisu-Itakura, Jonathan H Lee, Randall P Scheri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodesJonathan H Lee, Hitoe Torisu-Itakara, Alistair J Cochran, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Cancer Journal (Sudbury, Mass.)|June 29, 2006
Can surgical therapy alone achieve long-term cure of melanoma metastatic to regional nodes?Shawn E Young, Steve R Martinez, Mark B Faries, et al.
Journal of Cutaneous Pathology|January 12, 2019
Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimenAndrew B Siref, Carissa A T Huynh, Bonnie L Balzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Humoral immune response to a therapeutic polyvalent cancer vaccine after complete resection of thick primary melanoma and sentinel lymphadenectomyMathew H Chung, Rishab K Gupta, Eddy Hsueh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2005
Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanomaJohn C Kang, Leslie A Wanek, Richard Essner, et al.
JAMA Surgery|July 23, 2025
Metastatic Melanoma Outcomes and the Evolving Role of Surgery in the Immunotherapy EraHilary R Keller, Douglas A Hanes, Jillian K McCabe, et al.
Dermatology and Therapy|June 23, 2026
Comparing the i31-SLNB and the MIA Nomogram for Sentinel Lymph Node Biopsy Positivity Prediction in Cutaneous Melanoma: A Prospective Cohort AnalysisRohit Sharma, Rajan P Kulkarni, Richard Essner, et al.
Clinical Nuclear Medicine|December 10, 2003
The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision makingSeza A Gulec, Mark B Faries, Chris C Lee, et al.
Cancer Medicine|November 29, 2024
Individualized Prediction for Risk of Recurrence in Stage I/II Melanoma Patients With Negative Sentinel Lymph NodeShu-Ching Chang, Kristel Lourdault, Gary L Grunkemeier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanomaHitoe Torisu-Itakura, Jonathan H Lee, Randall P Scheri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodesJonathan H Lee, Hitoe Torisu-Itakara, Alistair J Cochran, et al.
Pageof 8